Home Compare AMGN vs GMAB.CO
Stock Comparison · Structural lead, mixed market

Amgen vs Genmab A/S: Which Stock Looks Stronger in 2026?

Amgen holds the cleaner structural position, with growth as the main driver and stability adding further support. Genmab A/S does not offset that deficit through any equally strong structural edge elsewhere. The market setup broadly confirms the structural lead — Amgen holds the more constructive position. That puts structure and market broadly in agreement — Amgen's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-09

Most of the visible separation comes from growth. Amgen Inc. leads by 20 points on the overall comparison score.

Trajectory Similarity
0.71
Similar
Peer-set rank: #1
within Amgen Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The clearest structural overlap shows up in investment intensity and margin trend.

Similarity drivers
investment intensitymargin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AMGN
Amgen Inc.
65
Peer-Score
Signal qualityHigh
vs
GMAB.CO
Genmab A/S
45
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: AMGN vs GMAB.CO Profitability 50 46 Stability 57 40 Valuation 77 66 Growth 75 17 AMGN GMAB.CO
Gap Ranking
#1 Growth +58
#2 Stability +17
#3 Valuation +11
#4 Profitability +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AMGN and GMAB.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AMGNGMAB.CO Relative valuation Structural strength

Amgen Inc. looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, Amgen Inc. ranks near the top of the group; Genmab A/S sits in the weaker half.
Stability
On stability, the same pattern holds: both rank well, but Amgen Inc. still sits higher.
Growth — Dominant Gap
AMGN
75
GMAB.CO
17
Gap+58in favour of AMGN

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Genmab A/S still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Growth is the clearest driver, and stability also supports Amgen Inc.'s broader structural position.

Explore full peer positioning in AssetNext

Break down the AMGN vs GMAB.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-driven comparisons

Explore how AMGN and GMAB.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.